Anna Macià

6PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosisMolecular targetsMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 14, 2025
High Copy Number Variations Correlate with a Pro-Tumoral Microenvironment and Worse Prognosis in Acral Lentiginous Melanoma.

Inés de la Rosa, Pol Sisó, Christopher Ríos

|Dec 17, 2024
Advances in Immunotherapy for Endometrial Cancer: Insights into MMR Status and Tumor Microenvironment.

Manel Albertí-Valls, Sara Olave, Anna Olomí

|Jan 11, 2024
Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review.

Manel Albertí-Valls, Cristina Megino-Luque, Anna Macià

|Jun 20, 2022
M-CSF as a therapeutic target in BRAF<sup>V600E</sup> melanoma resistant to BRAF inhibitors.

C Barceló, P Sisó, I de la Rosa

|Oct 23, 2021
<i>BRAF</i> Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics.

Xavier Soria, Felip Vilardell, Óscar Maiques

|Feb 13, 2020
T-Type Calcium Channels: A Potential Novel Target in Melanoma.

Carla Barceló, Pol Sisó, Oscar Maiques

Pageof 1

Frequent Collaborators

4 joint publications

Rosa M Martí

2 joint publications

Oscar Maiques

2 joint publications

Xavier Matias-Guiu

1 joint publications

R Navaridas